We’re continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology.
In his talk, The Reversal of the Aging of Human Cells: Strategies for Clinical Implementation, Dr. West discussed the differences between germ-line and somatic cells, embryonic regeneration in humans, organisms that do not age, the Weismann Barrier, the ways in which cellular immortality is repressed in human beings (somatic restriction), cellular reprogramming, and how AgeX is attempting to create stem cell populations for regenerative therapies.






Malignant tumors release cells into a patient’s blood, meaning that researchers could detect the presence of cancer through a blood sample. The problem is that the cancerous cells enter the bloodstream and circulate so quickly that they may not appear in one single blood sample. This issue is what sparked Dr. Hayes and his team to develop a device that actually searches for the cancerous cells.
